Stay updated on SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial

Sign up to get notified when there's something new on the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3. It appears to be an internal version update and does not alter the study details or page content.
    Difference
    0.1%
    Check dated 2026-03-07T06:43:42.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page revision updated to v3.4.2 from v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T15:42:22.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 with no visible changes to study content, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T11:17:06.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Glossary UI options (Show glossary / Hide glossary) were added. Metadata lines were updated to include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while the older QC-related entry and Revision: v3.3.4 were removed.
    Difference
    0.4%
    Check dated 2026-01-23T04:47:11.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4; Deleted Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-16T01:12:31.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added a footer note 'Revision: v3.3.3'; removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer.
    Difference
    0.1%
    Check dated 2025-12-18T21:04:55.000Z thumbnail image

Stay in the know with updates to SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page.